NCT05406960 (HERBALTREAT) is a NA clinical trial of Tea infusion in Abnormal Uterine Bleeding, sponsored by Faculty of Medicine, Sousse.

Who is sponsoring NCT05406960?

NCT05406960 is sponsored by Faculty of Medicine, Sousse.

What drugs are being tested in NCT05406960?

Interventions in NCT05406960: Tea infusion.

What condition does NCT05406960 study?

NCT05406960 studies Abnormal Uterine Bleeding, Menorrhagia; Postmenopausal, Metrorrhagia, Hysterectomy, Heavy Menstrual Bleeding.

Is NCT05406960 still recruiting?

NCT05406960 is currently completed. Last updated 7 June 2022.

Last reviewed 2022-06-07 · How we verify

NCT05406960: HERBALTREAT

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Therapeutic Effect of Herbal Infusion on Menometrorrhagia

Completed NA Last updated 7 June 2022

What this trial tests

NA trial testing Tea infusion in Abnormal Uterine Bleeding in 13 participants. Completed in 10 February 2021.

Timeline

10 May 2019

Primary endpoint
20 December 2020

10 February 2021

Quick facts

Lead sponsor	Faculty of Medicine, Sousse
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	treatment
Enrollment	13
Start date	10 May 2019
Primary completion	20 December 2020
Estimated completion	10 February 2021
Sites	1 location across Tunisia

Drugs / interventions tested

Tea infusion

Conditions studied

Abnormal Uterine Bleeding — all drugs for Abnormal Uterine Bleeding →
Menorrhagia; Postmenopausal — all drugs for Menorrhagia; Postmenopausal →
Metrorrhagia — all drugs for Metrorrhagia →
Hysterectomy — all drugs for Hysterectomy →

Sponsor

Faculty of Medicine, Sousse

Who can join

Adults 30 to 55, female only, with Abnormal Uterine Bleeding or Menorrhagia; Postmenopausal. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This is an interventional, non-randomized, controlled, pilot study that explores a new approach to treat, Abnormal uterine bleeding-menometrorrhagia in women, being candidates for hysterectomy, based on tea infusion consumption of a mixture of two plants.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Therapeutic effect of herbal infusion on abnormal uterine bleeding: interventional non-randomized pilot study
Selmi M, Lassoued L, Bannour B, Chbili C, et al · · 2022 · DOI 10.12688/f1000research.122435.1

Verify or expand the search:

Other trials of Tea infusion

Trials testing the same drug.

NCT05824039 — Safety and Efficacy of Medicinal Plant Extract in Overweight and Obese Participants. · NA · completed

Other recruiting trials for Abnormal Uterine Bleeding

Currently open trials in the same condition.

NCT07349108 — Comparison of Manual Vacuum Aspiration and Dilatation and Curettage for Endometrial Sampling Adequacy in Women With Abno · NA · active not recruiting
NCT06653400 — Combined Ketorolac and Lidocaine Paracervical Block for Office Hysteroscopy · Phase 1 · recruiting
NCT07496905 — The Effect of the Valsalva Maneuver in Endometrial Biopsy: A Randomized Controlled Trial · NA · recruiting
NCT07169214 — Evaluation of Safety, Efficacy, and Pharmacokinetics of BT-114143 Injection in Patients With Abnormal Uterine Bleeding · Phase 1 · recruiting
NCT07183501 — Combined Hystroscopic and Laparoscopic Repair of CS Scar Disorder · NA · recruiting

Other Faculty of Medicine, Sousse trials

Trials by the same sponsor.

NCT07096037 — Safety and Efficacy of Urtica Dioica Cataplasm in the Management of Osgood-Schlatter Disease in Young Athletes · NA · not yet recruiting
NCT06926114 — Is Microlearning the Alternative in the Age of Hyperconnectivity · NA · enrolling by invitation
NCT06021834 — Effect of Physical Rehabilitation in Patients With Parkinson's Disease · NA · unknown
NCT06948669 — Brain Death and Organ Donation in Tunisian Intensive Care Units · completed
NCT07271550 — NAFF Arabic Validation Study · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05406960 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Faculty of Medicine, Sousse
Last refreshed: 7 June 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05406960.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing